NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/10/2024
Back to search
Official data from USPTO
ENOVACHEM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ENOVACHEM
ST13
US500000086097325Class
5, 39, 40
Filing
86097325
Registration
4583218
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
08/10/2024
Trademark type
Word
Nice classes
5, 39, 40
Filing date
10/21/2013
Registration date
08/12/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/10/2024
Last transaction
08/10/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
05/21/2012
First use in commerce
05/31/2012
Drawing code
4
Owner type
03
Owner location
Torrance, CA, US
Examiner
SPARACINO, MARK V
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Asclemed USA, Inc.
Representatives
Irene Y. Lee Russ, August & Kabat
Technical classification
Nice Classes
Class 5Class 39Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropsliquid vialsmedicinal preparationsfor prevention of flufor relief of headachesprevention of anemiaprevention of peripheral neuropathyfor use as an anestheticfor use as an anti-inflammatoryfor treatment of incomplete or infrequent bowel movements; Medicinal preparationscreamsgels for physicians' ready useibuprofen cream and cyclobenzaprine cream for treatment of inflammationpain and burn for skin diseases and for treatment of pain and stiffness caused by muscle spasms; Medicinal kits comprised of pillstabletscapsulescapletsliquid dropsliquid vialsmedicinal preparations for prevention of the flufor relief of headachesprevention of anemiaprevention of peripheral neuropathyfor use as an anestheticfor use as an anti-inflammatoryfor treatment of incomplete or infrequent bowel movements; nutritional supplements; facial treatment preparations for scars
Class 39
merchandise packaging of prescription and non-prescription medicinesnutritional supplementsfacial treatment for scardrugscontrolled substances; merchandise packaging services serving physicianspharmaciesmanufacturerswholesalersdistributors
Class 40
custom manufacturing of prescription and non-prescription medicinesnutritional supplementsfacial treatment for scardrugscontrolled substances for physicianspharmaciesmanufacturerswholesalersdistributors
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/10/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/10/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
05/23/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/12/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/26/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/26/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/26/2019
E815
TEAS SECTION 8 & 15 RECEIVED
08/19/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/12/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/18/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
08/12/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/27/2014
PUBO
PUBLISHED FOR OPPOSITION
05/27/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/07/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/23/2014
ALIE
ASSIGNED TO LIE
04/23/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/11/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/06/2014
GNFR
FINAL REFUSAL E-MAILED
03/06/2014
CNFR
FINAL REFUSAL WRITTEN
03/06/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/27/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/26/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/10/2014
GNRT
NON-FINAL ACTION E-MAILED
02/10/2014
CNRT
NON-FINAL ACTION WRITTEN
02/10/2014
DOCK
ASSIGNED TO EXAMINER
02/04/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/26/2013
Continuous trademark protection
Get notified about every new filing that threatens ENOVACHEM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.